Medical Progress Report No. 2  October 2005


Older Drugs, Shorter Lives? An Examination of the Health Effects of the Veterans Health Administration Formulary

Appendix Table 1: Priority Review Drugs Approved After 1997 Not Listed on 2005 National Formulary

ABARELIX

MIFEPRISTONE

ACAMPROSATE

NATALIZUMAB

ADEFOVIR

NITAZOXANIDE

ALITRETINOIN

NITISINONE

ALOSETRON

NITRIC OXIDE

ANAGRELIDE

ORLISTAT

APREPITANT

OSELTAMIVIR

ARSENIC

PEGVISOMANT

AZACITIDINE

PEMETREXED

BEVACIZUMAB

PEMIROLAST

BEXAROTENE

PIOGLITAZONE

BIMATOPROST

RALOXIFENE

BORTEZOMIB

REPAGLINIDE

CAPECITABINE

RIFAPENTINE

CASPOFUNGIN

ROFECOXIB

CELECOXIB

SACROSIDASE

CETUXIMAB

SIROLIMUS

CINACALCET

SODIUM OXYBATE

DALFOPRISTIN/QUINUPRISTIN

TEGASEROD

DAPTOMYCIN

TEMOZOLOMIDE

EPIRUBICIN

THALIDOMIDE

EPTIFIBATIDE

THYROTROPIN ALFA

ERLOTINIB

TIROFIBAN

FOMIVIRSEN

TREPROSTINIL

FONDAPARINUX

TROGLITAZONE

GANIRELIX

UNOPROSTONE

GEFITINIB

VALRUBICIN

KETOTIFEN

VERTEPORFIN

LEFLUNOMIDE

ZANAMIVIR

LEPIRUDIN

ZOLEDRONIC

[figure 1] [figure 2] [figure 3] [figure 4] [appendix table 1] [appendix table 2]